352 related articles for article (PubMed ID: 36587121)
1. In Vivo Analysis of Tumor-Associated Macrophages in the Tumor Microenvironment.
Anfray C; Ummarino A; Calvo A; Allavena P; Torres Andón F
Methods Mol Biol; 2023; 2614():93-108. PubMed ID: 36587121
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer.
Li C; Xu X; Wei S; Jiang P; Xue L; Wang J;
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33504575
[TBL] [Abstract][Full Text] [Related]
3. Targeting tumor-associated macrophages as an antitumor strategy.
Cheng N; Bai X; Shu Y; Ahmad O; Shen P
Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity.
Anfray C; Mainini F; Digifico E; Maeda A; Sironi M; Erreni M; Anselmo A; Ummarino A; Gandoy S; Expósito F; Redrado M; Serrano D; Calvo A; Martens M; Bravo S; Mantovani A; Allavena P; Andón FT
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34531246
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
[TBL] [Abstract][Full Text] [Related]
6. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages.
Wang Y; Wang D; Yang L; Zhang Y
Chin Med J (Engl); 2022 Oct; 135(20):2405-2416. PubMed ID: 36385099
[TBL] [Abstract][Full Text] [Related]
7. Harnessing tumor-associated macrophages as aids for cancer immunotherapy.
Li X; Liu R; Su X; Pan Y; Han X; Shao C; Shi Y
Mol Cancer; 2019 Dec; 18(1):177. PubMed ID: 31805946
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy.
Khan SU; Khan MU; Azhar Ud Din M; Khan IM; Khan MI; Bungau S; Hassan SSU
Front Immunol; 2023; 14():1166487. PubMed ID: 37138860
[TBL] [Abstract][Full Text] [Related]
9. The cross-talk between tumor-associated macrophages and tumor endothelium: Recent advances in macrophage-based cancer immunotherapy.
Baradaran A; Asadzadeh Z; Hemmat N; Baghbanzadeh A; Shadbad MA; Khosravi N; Derakhshani A; Alemohammad H; Afrashteh Nour M; Safarpour H; Silvestris N; Brunetti O; Baradaran B
Biomed Pharmacother; 2022 Feb; 146():112588. PubMed ID: 35062062
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated macrophages: new insights on their metabolic regulation and their influence in cancer immunotherapy.
Xiao L; Wang Q; Peng H
Front Immunol; 2023; 14():1157291. PubMed ID: 37426676
[TBL] [Abstract][Full Text] [Related]
11. Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing.
Zins K; Abraham D
Methods Mol Biol; 2020; 2115():289-325. PubMed ID: 32006408
[TBL] [Abstract][Full Text] [Related]
12. Targeting tumor-associated macrophages to reverse antitumor drug resistance.
Li S; Sheng J; Zhang D; Qin H
Aging (Albany NY); 2024 May; 16(11):10165-10196. PubMed ID: 38787372
[TBL] [Abstract][Full Text] [Related]
13. Macrophage targeting in cancer.
Lopez-Yrigoyen M; Cassetta L; Pollard JW
Ann N Y Acad Sci; 2021 Sep; 1499(1):18-41. PubMed ID: 32445205
[TBL] [Abstract][Full Text] [Related]
14. The role of tumor-associated macrophages in tumor immune evasion.
Huang R; Kang T; Chen S
J Cancer Res Clin Oncol; 2024 May; 150(5):238. PubMed ID: 38713256
[TBL] [Abstract][Full Text] [Related]
15. The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment.
Li L; Tian Y
Biomed Pharmacother; 2023 May; 161():114504. PubMed ID: 37002579
[TBL] [Abstract][Full Text] [Related]
16. Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma.
Truxova I; Cibula D; Spisek R; Fucikova J
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822672
[TBL] [Abstract][Full Text] [Related]
17. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
Gao J; Liang Y; Wang L
Front Immunol; 2022; 13():888713. PubMed ID: 35844605
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Associated Macrophage Subsets: Shaping Polarization and Targeting.
Zhang Q; Sioud M
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108657
[TBL] [Abstract][Full Text] [Related]
19. Targeting tumor-associated macrophages for cancer immunotherapy.
Cao X; Lai SWT; Chen S; Wang S; Feng M
Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated macrophages in tumor progression and the role of traditional Chinese medicine in regulating TAMs to enhance antitumor effects.
Zhang J; Gao J; Cui J; Wang Y; Jin Y; Zhang D; Lin D; Lin J
Front Immunol; 2022; 13():1026898. PubMed ID: 36311793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
